Literature DB >> 20336460

Pattern-based diagnosis and screening of differentially expressed serum proteins for rheumatoid arthritis by proteomic fingerprinting.

Li Long1, Ru Li, Yongzhe Li, Chaojun Hu, Zhanguo Li.   

Abstract

The objective of this study was to search for proteomic patterns distinguishing patients with rheumatoid arthritis (RA) from healthy controls, biomarker candidates specific for early RA, and proteins reflecting disease activity, by profiling of serum proteins using magnetic bead-based (MB) separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). Magnetic chemical affinity beads were used to differentially capture serum proteins prior to MALDI-TOF analysis. Seventy serum samples from patients with RA and 50 from healthy controls were analyzed. The samples were randomly allocated to the training set or test set to develop a pattern by means of decision tree algorithm. ANOVA test was utilized to search for biomarkers for early RA. Pearson correlation analysis was employed to estimate the overexpressed peaks in relation to Disease Activity Score (DAS)28. The algorithm identified a pattern based on 3 peaks (m/z 2,490, 5,910.07, 6,436.73) that, in the training set, separated patients with RA from healthy controls with a sensitivity and specificity of 87.5 and 96.7%, respectively. Blind test data indicated a sensitivity of 86.7% and specificity of 90%. The peaks of m/z 1,014.92 and 1,061.38 were raised significantly in early RA group (disease duration <12 months) compared with those in non-early RA group (disease duration ≥12 months) and healthy controls. A positive correlation was found between the intensity of peak 9,591.47 and DAS28 scores. Using MB separation followed by MALDI-TOF-MS enabled rapid diagnosis of RA according to fingerprint pattern, a method which might also help to assess disease activity and identify early RA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336460     DOI: 10.1007/s00296-010-1407-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

Review 1.  The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria.

Authors:  David L Scott
Journal:  Arthritis Rheum       Date:  2002-02

2.  Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.

Authors:  Dominique de Seny; Marianne Fillet; Marie-Alice Meuwis; Pierre Geurts; Laurence Lutteri; Clio Ribbens; Vincent Bours; Louis Wehenkel; Jacques Piette; Michel Malaise; Marie-Paule Merville
Journal:  Arthritis Rheum       Date:  2005-12

Review 3.  Proteomic technologies and their application to pancreatic cancer.

Authors:  Dale Vimalachandran; Eithne Costello
Journal:  Expert Rev Proteomics       Date:  2004-12       Impact factor: 3.940

4.  Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Authors:  Gary L Freed; Lisa H Cazares; Craig E Fichandler; Thomas W Fuller; Christopher A Sawyer; Brendan C Stack; Scott Schraff; O John Semmes; J Trad Wadsworth; Richard R Drake
Journal:  Laryngoscope       Date:  2008-01       Impact factor: 3.325

5.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

6.  How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis.

Authors:  Henk Visser; Saskia le Cessie; Koen Vos; Ferdinand C Breedveld; Johanna M W Hazes
Journal:  Arthritis Rheum       Date:  2002-02

7.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

8.  Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology.

Authors:  Ann-Joy Cheng; Li-Chiu Chen; Kun-Yi Chien; Yin-Ju Chen; Joseph Tung-Chieh Chang; Hung-Ming Wang; Chun-Ta Liao; I-How Chen
Journal:  Clin Chem       Date:  2005-10-20       Impact factor: 8.327

9.  Enrichment and detection of molecules secreted by tumor cells using magnetic reversed-phase particles and LC-MALDI-TOF-MS.

Authors:  Jochen F Peter; Angela M Otto; Bernhard Wolf
Journal:  J Biomol Tech       Date:  2007-12

10.  Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.

Authors:  W Liu; X Li; F Ding; Y Li
Journal:  Scand J Rheumatol       Date:  2008 Mar-Apr       Impact factor: 3.641

View more
  2 in total

1.  New detection method in experimental mice for schistosomiasis: ClinProTool and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Yuzheng Huang; Wei Li; Kun Liu; Chunrong Xiong; Peng Cao; Jianping Tao
Journal:  Parasitol Res       Date:  2016-07-29       Impact factor: 2.289

2.  Establishment of a novel diagnostic model for Sjögren's syndrome by proteomic fingerprinting.

Authors:  Yuhui Li; Xiaolin Sun; Xuewu Zhang; Yuqin Yang; Rulin Jia; Xu Liu; Ru Li; Yanying Liu; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2014-09-02       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.